Meclomen side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Meclomen. Common side effects include drug hypersensitivity among females, and abdominal discomfort among males.
The phase IV clinical study is created by eHealthMe based on 77 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
77 people who take Meclomen and have side effects are studied.
What is Meclomen?
Meclomen has active ingredients of meclofenamate sodium. Currently, eHealthMe is studying from 77 Meclomen users.
Number of Meclomen reports submitted per year:

Meclomen side effects by gender *:
female:
- Drug hypersensitivity
- Abdominal distension
- Agitation (state of anxiety or nervous excitement)
- Asthenia (weakness)
- Arthralgia (joint pain)
- Blood glucose increased
- Hypersensitivity
- Abnormal dreams
- Activated partial thromboplastin time prolonged
- Activated partial thromboplastin time shortened
male:
- Abdominal discomfort
- Drug hypersensitivity
- Hypercholesterolaemia (high levels of cholesterol in the blood)
- Abasia (inability to walk)
- Acute circulatory failure (shock)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Blood creatinine increased
- Confusion
- Haemarthrosis (haemarthrosis is where blood is able to enter the joint capsule)
Meclomen side effects by age (0-1 to 60+) *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Actinomyces test positive
- Haemarthrosis (haemarthrosis is where blood is able to enter the joint capsule)
- Rash vesicular (rash with a small bubble)
30-39:
- Asthenia (weakness)
- Activated partial thromboplastin time prolonged
- Activated partial thromboplastin time shortened
- Ascites (accumulation of fluid in the abdominal cavity)
40-49:
- Abdominal distension
- Drug hypersensitivity
- Chest pain
- Hypercholesterolaemia (high levels of cholesterol in the blood)
50-59:
- Abdominal discomfort
- Arthralgia (joint pain)
- Alopecia (absence of hair from areas of the body)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Arthropathy
60+:
- Agitation (state of anxiety or nervous excitement)
- Blood glucose increased
- Actinomyces test positive
- Acute circulatory failure (shock)
- Back pain
- Confusion
- Drooling (drop saliva uncontrollably from the mouth)
- Drug ineffective
- Drug maladministration
- Dysphagia (condition in which swallowing is difficult or painful)
* Approximation only. Some reports may have incomplete information.
Do you take Meclomen?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on meclofenamate sodium (the active ingredients of Meclomen) and Meclomen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Meclomen:
- Meclomen (77 reports)
All Meclomen side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Yasmin and Sporanox drug interaction - 7 seconds ago
- Fioricet and Doxycycline drug interaction - 25 seconds ago
- Erelzi and Pain - a minute ago
- Centrum Silver and Kidney Stones - a minute ago
- Lipitor and Beta 2 Microglobulin Urine Increased - a minute ago
- Erelzi and Malaise - a minute ago
- Byetta and Injection Site Urticaria - 2 minutes ago
- Humira and Injection Site Urticaria - 2 minutes ago
- Metformin and Injection Site Urticaria - 2 minutes ago
- Flolan and Dizziness - 2 minutes ago